H. Lundbeck AS (LTS:0ND5) Long-Term Capital Lease Obligation : kr361 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Long-Term Capital Lease Obligation?

H. Lundbeck AS's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr361 Mil.

H. Lundbeck AS's quarterly Long-Term Capital Lease Obligation stayed the same from Sep. 2023 (kr351 Mil) to Dec. 2023 (kr351 Mil) but then increased from Dec. 2023 (kr351 Mil) to Mar. 2024 (kr361 Mil).

H. Lundbeck AS's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (kr453 Mil) to Dec. 2022 (kr395 Mil) and declined from Dec. 2022 (kr395 Mil) to Dec. 2023 (kr351 Mil).

H. Lundbeck AS Long-Term Capital Lease Obligation Historical Data

The historical data trend for H. Lundbeck AS's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Long-Term Capital Lease Obligation Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

437.00

416.00

453.00

395.00

351.00

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															370.00	362.00	351.00	351.00	361.00

H. Lundbeck AS (LTS:0ND5) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

H. Lundbeck AS Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (LTS:0ND5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (LTS:0ND5) Headlines

No Headlines